Medici per Carcinosi all'estero — Pagina 2

Il Dr. Ari Raphael guida le sperimentazioni oncologiche e la ricerca genomica presso il Sourasky Medical Center, specializzandosi nel cancro ai polmoni e al seno.

• Docente senior presso la Facoltà di Medicina dell'Università di Tel Aviv
• Ricercatore principale per numerosi studi clinici nel NSCLC
• Esperto in biopsie liquide e profilazione genomica completa
• Moderatore della Molecular Tumor Board per la Società Israeliana del Cancro ai Polmoni
• Destinatario della borsa di studio ISCORT per la ricerca e onorificenze all'insegnamento

Dr. Sezer Saglam is a medical oncologist at Gayrettepe Florence Nightingale Hospital in Istanbul. He specializes in treating gastrointestinal and breast cancers. His research on rectal cancer timing has influenced global treatment protocols. Dr. Saglam develops personalized therapy plans using targeted medicine and precision techniques.

• Nominated for the International Best Researcher Award for work on liver cancer.
• Leads clinical trials focused on targeted therapies and precision oncology.
• Member of the American Society of Clinical Oncology (ASCO).
• Certified by the European Society for Medical Oncology (ESMO).

La dottoressa è un chirurgo oncologico specializzato in carcinosi peritoneale e fa parte del Gruppo Chirurgico di Carcinosi dell'Istituto Oncologico Teknon dal 2019. Ha completato la sua specializzazione al Washington Hospital Center sotto la guida del Prof. Paul Sugarbaker e possiede la certificazione dell'American Board of Surgery.<\/p>

È membro di diverse società prestigiose, tra cui l'American College of Surgeons e la Society of Surgical Oncology. I suoi ruoli accademici hanno incluso il Direttore della Ricerca presso l'Inova Fairfax Hospital e posizioni di Professore Associato presso la Virginia Commonwealth University e la Georgetown University.<\/p>

Oltre 1.100 procedure oncologiche eseguite – La Prof.ssa Elke Jaeger dirige Oncologia ed Ematologia presso la Nordwest Clinic.

• 39 anni di esperienza in oncologia
• Riconosciuta tra i migliori oncologi in Germania da 20 anni
• Professore di oncologia medica con oltre 7.000 citazioni
• Specializzata nel trattamento dei sarcomi

Il medico è un chirurgo addominale specializzato in procedure sia aperte che minimamente invasive, inclusa la chirurgia di Whipple. Con oltre 20 anni di esperienza, il medico guida il Dipartimento di Chirurgia Colorettale al Sourasky Medical Center, dimostrando competenza nelle tecniche chirurgiche avanzate e nella cura del paziente.<\/p>

Dr. Ozcan Yildiz is an oncologist and hematologist at Medipol Mega University Hospital in Istanbul. He specializes in treating complex neuroendocrine tumors and gynecological cancers. Dr. Yildiz has published numerous studies in prestigious journals like Medical Oncology and International Journal of Cardiology. He works at a JCI-accredited facility recognized for its bone marrow transplant expertise.

• Expertise in treating lung, breast, and gastrointestinal cancers.
• Treats hematological conditions including idiopathic thrombocytopenia.
• Published research on thyroid therapy and steroid synthesis safety.
• Performs specialized procedures like leukemia chemotherapy and tumor biopsies.

Il medico è un distinto oncologo medico e internista austriaco con oltre due decenni di esperienza, specializzato in cancro al seno, neoplasie ginecologiche e terapie mirate contro il cancro. Laureato all'Università di Vienna, il medico ha completato la residenza in medicina interna e oncologia medica presso l'Università Medica di Vienna. Il medico ha contribuito ai primi studi clinici sulle terapie mirate ed è un'autorità leader nel trattamento personalizzato del cancro.<\/p>

Attualmente serve come consulente senior presso il Wiener Privatklinik e continua il lavoro accademico presso l'Università Medica di Vienna, il medico si concentra sulla terapia sistemica individualizzata del cancro, l'immunoterapia e la ricerca oncologica traslazionale. La ricerca del medico include lo sviluppo di biomarcatori e meccanismi di resistenza ai farmaci mirati, con pubblicazioni su riviste internazionali di spicco.<\/p>

Primario presso un centro oncologico multidisciplinare certificato, il Dr. Fox guida trattamenti innovativi per le malattie emato-oncologiche.

• Specializzato in chemioterapia, immunoterapia e terapie mirate
• Membro attivo di società oncologiche tedesche e americane
• Esperto in diagnostica molecolare e genetica
• Ricercatore pubblicato nei trattamenti emato-oncologici

Il Professor Keil è specializzato in radiologia diagnostica e interventistica, con un focus su tecniche di imaging avanzate per casi complessi.

• Laureato con lode presso la Julius-Maximilians-Universität Würzburg
• Medico di spicco presso l'Ospedale Universitario di Aquisgrana sotto rinomati professori
• Primario presso l'Ospedale Accademico di Solingen dal 2022
• Esperto in diagnostica MRI, TC e ad ultrasuoni

Il medico è un immunologo con oltre 30 anni di esperienza, specializzato in viroterapia, un campo all'avanguardia nell'immunologia. <\/p>

Si è laureato presso l'Istituto Medico di Riga e ha completato un tirocinio in Medicina Interna. <\/p>

Attualmente è il capo del Centro di Immunologia Clinica presso l'Ospedale Universitario Clinico Pauls Stradins.<\/p>

La Dott.ssa Séverine Iborra dirige il Dipartimento di Ginecologia e Ostetricia presso il Städtisches Klinikum Solingen, specializzandosi in oncologia ginecologica e procedure minimamente invasive.

• Certificata in diagnostica e terapia oncologica dal Gruppo di Lavoro di Oncologia Ginecologica
• Esperta in interventi chirurgici laparoscopici e robot-assistiti, incluso il sistema Da Vinci
• Membro attivo delle principali società mediche tedesche in ginecologia
• Possiede qualifiche aggiuntive in Patologia Cervicale e Colposcopia

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Education

Ondokuz Mayıs University Faculty of Medicine (1991)

KTÜ Faculty of Medicine Farabi Hospital (Specialization.1998)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Surgery Training, 2002)

Istanbul University Çapa Faculty of Medicine (Laparoscopic Antireflux Surgery Training, 2006)

Istanbul University Cerrahpaşa Faculty of Medicine (General Surgery Clinic Advance Laparoscopic Surgery, Laparoscopic Bariatric Surgery, Morbid Obesity and Oncological Cancer Surgery Training, 2010i)

Dr. Gul Alco is a radiation oncologist and Professor at Medipol Acibadem District Hospital in Istanbul. She excels in treating complex cases, including stage 4 lung and liver cancers. Dr. Alco utilizes the CyberKnife and Da Vinci robotic systems for precise tumor targeting. She works at a JCI-accredited facility known for its high safety standards.

• Specializes in brachytherapy and high-intensity focused ultrasound ablation (HIFU).
• Performs radiofrequency ablation and proton-beam therapy for various malignancies.
• Treats pancreatic, breast, ovarian, and brain cancers using targeted radiation.
• Expert in nuclear medicine diagnostics, including PET-CT with Gallium 68.

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.